Patents by Inventor Aaron Ball

Aaron Ball has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240070256
    Abstract: In certain aspects of the present disclosure, a computer-implemented includes generating a unique code for display on a managed device, and authorizing a manager device to selectively initiate at least one workflow on the managed device. The method includes, responsive to the manager device scanning the unique code, verifying the manager device is authorized. The method includes displaying on the manager device, based on verification that the manager device is authorized, an option corresponding to the at least one workflow. The method includes receiving, from the manager device, a selected workflow. The method includes, responsive to receiving the selected workflow, transmitting a message to a push notification server initiating the managed device to communicate with an MDM server. The method includes transmitting a command to the managed device causing performance of the selected workflow on the managed device. Systems and machine-readable media are also provided.
    Type: Application
    Filed: August 30, 2022
    Publication date: February 29, 2024
    Inventors: Aaron Maxim, Adam Mahmud, Christopher Ball, Jonathan William Yuresko, Tim Knox
  • Publication number: 20240060107
    Abstract: A method for in vitro transcription of a DNA template into RNA includes providing a mixture containing a buffer substance, ribonucleoside triphosphates (NTPs), one or more magnesium salts in a concentration of from about 2 mM to about 60 mM, the DNA template, and a recombinant RNA polymerase, and incubating the reaction mixture at from about 25° C. to about 40° C. for from about 1 hour to about 12 hours thereby producing the RNA. A method for in vitro transcription includes providing a DNA template and a cap analogue that binds to ?1 and/or +1 nucleotides of promoter for in vitro transcription, thus producing more full length mRNAs, allowing for more flexibility on the choice of first mRNA base, and providing +2 position open for custom sequence.
    Type: Application
    Filed: December 20, 2022
    Publication date: February 22, 2024
    Inventors: Cheng-Hsien WU, Fengmei PI, Robert DEMPCY, Shambhavi SHUBHAM, Kristine BIELECKI, Aaron BALL
  • Patent number: 11898186
    Abstract: A method for in vitro transcription of a DNA template into RNA includes providing a mixture containing a buffer substance, ribonucleoside triphosphates (NTPs), one or more magnesium salts in a concentration of from about 2 mM to about 60 mM, the DNA template, and a recombinant RNA polymerase, and incubating the reaction mixture at from about 25° C. to about 40° C. for from about 1 hour to about 12 hours thereby producing the RNA. A method for in vitro transcription includes providing a DNA template and a cap analogue that binds to ?1 and/or +1 nucleotides of promoter for in vitro transcription, thus producing more full length mRNAs, allowing for more flexibility on the choice of first mRNA base, and providing +2 position open for custom sequence.
    Type: Grant
    Filed: December 20, 2022
    Date of Patent: February 13, 2024
    Assignee: GENSCRIPT USA INC.
    Inventors: Cheng-Hsien Wu, Fengmei Pi, Robert Dempcy, Shambhavi Shubham, Kristine Bielecki, Aaron Ball